C‐reactive protein as a predictor of low trough infliximab concentrations in patients who lose response to infliximab

E-ISSN： 1751-2980|18|12|678-683

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.18, Iss.12, 2017-12, pp. : 678-683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etanercept appears to be effective for patients with rheumatoid arthritis (RA) who fail to achieve or maintain an adequate response to infliximab

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Infliximab

By Valle Emil Bickston Stephen J Gross Meredith

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1015-1025

Informa Healthcare

Access to resources Recommend Favorite

Plasma Concentrations of C-reactive Protein and Fibrinogen in Ischaemic Stroke

By İyigün İ Bakirci Y

The Journal of International Medical Research, Vol. 30, Iss. 6, 2002-11 ,pp. : 591-596

Field House Publishing

Access to resources Recommend Favorite

A sustained response to infliximab may be seen in paediatric patients with early CD

Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Statins may benefit patients with high levels of C-reactive protein

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite